Frontlight ResearchEarly access
Active, not recruitingPhase 2
CIAO@TBI
Key facts
- Who runs it
- Leids Universitair Medisch Centrum (LUMC)
- Where
- Netherlands3 sites in 1 countryChoose a country to see its sites
- Status
- Active, not recruiting
- Phase
- Phase 2
- People taking part
- 106 people, planned
- Started
- 9 Oct 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Record updated
- 23 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Traumatic Brain Injury
- Age > 18 years
- GCS < 13
- ICP monitor
Who cannot take part
- < 18 years
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To study the safety and efficacy of C1-INH in patients with traumatic brain injury
Data and sources
- Registry record
- Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- (CIAO@TBI) Complement Inhibition: Attacking Overshooting Inflammation @fter traumatic brain injury
- Publications
- Record updated
- 23 January 2026